Navigation Links
Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment

The survival rate of patients with testicular cancer has increased significantly over the past several years. What more, new research has now shown that fatherhood is a reachable possibility for many men who survive the disease.//

Testicular cancer is the most common form of cancer among men ages 20 to 40 and is slightly more common on the right side than on the left. The cause for the cancer is not known exactly. However, a combination of congenital (present right form birth) and acquired factors is believed to play a significant role.

The most common symptom associated with testicular cancer is painless enlargement of the testis accompanied by a sensation of heaviness. Self-examination plays a very important role in the early detection and treatment of testicular cancer. Surgery, radiotherapy and chemotherapy are the treatment options available.

A ray of hope left for the patients affected with testicular cancer is that it has a high cure rate, if detected early. However, the treatment has been known to affect the fertility potential of the patient. A follow up study combined with research purpose, conducted on a group of testicular cancer patients revealed that about one-third of the follow up patients attempted to father a child after treatment. Seventy-one percent of the men were successful within 15 years of treatment and 76 percent had the same success within 20 years.

Furthermore, the chance of successful conception was found to be dependent on the type of treatment as anticipated. Men treatment with high doses of chemotherapy had a 48 % success while the success rate for those followed by surveillance alone after the cancerous testicle was removed was much higher (92 %). Assisted reproductive techniques have helped these patients to a larger extent (22 %). The study results highlight the finding that the ability to conceive has increased over the years. It would be important however to preserve the sperm sample by c ryopreservation prior to chemotherapy as it is impossible to predict the fertility outcome on an individual basis.

Related medicine news :

1. Fertility After Testicular Cancer Questioned
2. Life After Testicular Cancer
3. New Screening Method Found To Detect Testicular Cancer In Its Initial Stages
4. Testicular cancer linked to high cholesterol
5. Carboplatin Drug Is More Effective Than Radiation Therapy For Testicular Cancer
6. Treating Testicular Cancer With A Single Dose Of Chemotherapy
7. Testicular cancer identified
8. New Treatment Option For Testicular Cancer
9. Decline in Paternity Rates Following Treatment for Testicular Cancer
10. Human Testicular Cells Would Help In Stem Cell Research
11. An Eye on Increase in Testicular Cancer
Post Your Comments:

(Date:6/25/2016)... ... ... closing of Bruton Memorial Library on June 21 due to a possible lice infestation, as ... of head lice: the parasite’s ability to live away from a human host, and to ... one in the event that lice have simply gotten out of control. , As lice ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. ... The attorneys chosen by their peers for this recognition are considered among the top ... Shareholders received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Calif. , June 23, 2016 Any dentist ... many challenges of the current process. Many of them do ... of the technical difficulties and high laboratory costs involved. And ... to offer it at such a high cost that the ... it. Dr. Parsa Zadeh , founder of ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: